Loading...

Home
ETF
SILO

SILO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

SILO News

Silo Pharma Partners with Allucent to Advance SPC-15 Clinical Studies

Dec 30 2025Globenewswire

Silo Pharma Enters LOI with Allucent for SPC-15 Clinical Studies

Dec 30 2025Newsfilter

Silo Pharma Collaborates with Allucent to Assist in Upcoming FDA Investigational New Drug Application for SPC-15 as a PTSD Treatment

Nov 17 2025Newsfilter

Silo Pharma Provides Update on Progress in PTSD Drug Development and Launches New Digital Assets Treasury Initiative

Oct 23 2025Newsfilter

Silo Pharma Completes $2.5 Million Registered Direct Offering at Market Price in Compliance with Nasdaq Regulations

Oct 01 2025Newsfilter

Silo Pharma Unveils $2.5 Million Registered Direct Offering Priced According to Nasdaq Regulations

Sep 30 2025Newsfilter

Silo Pharma Enhances Strategic Partnership with Fireblocks for Secure Management of Crypto Treasury

Sep 29 2025Newsfilter

Silo Pharma Collaborates with Fireblocks to Enhance Crypto Treasury Strategy and Security Measures

Sep 23 2025Benzinga

EXCLUSIVE: Hoth Therapeutics' Antisense Treatment Shows Effectiveness in Targeting KIT-Driven Cancers

Sep 02 2025Benzinga

Silo Pharma's Alzheimer's Treatment SPC-14 Highlighted in Prestigious Scientific Journal

Aug 21 2025Newsfilter

Silo Pharma's SPC-15 for PTSD Reaches Key Safety Milestone, Clearing Path for Faster Clinical Trials via 505(b)(2) Pathway

Aug 19 2025Newsfilter

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 16 2025Newsfilter

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jul 07 2025Newsfilter

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25 2025Newsfilter

Hoth Therapeutics, Silo Pharma Launch JV To Commercialize VA-Invented Obesity Drug

Jun 25 2025NASDAQ.COM

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Jun 09 2025Benzinga